Abstract:Objective To investigate the characteristics and the frequencies of B cell subsets in peripheral blood of rheumatoid arthritis (RA) patients,and to study the correlation between B cell subsets and clinical indices and influence of different therapies on B cell subsets to deeply understand the pathogenesis of RA.Methods Peripheral blood witched memory B cells,non-switched memory B cells,naive B cells,and double negative B cells of 141 patients and 33 healthy controls were measured by flow cytometry.Patients were divided into three groups based on their therapeutic regimen,including tumor necrosis factor-or (TNF-α) inhibitors combined with disease modifying antirheumatic drugs (DMARDs),DMARDs only and patients without any therapy.The relevance between B cells subsets and clinical manifestations,lab test results exemption were assessed as well as the influence of different therapies.All data were were analyzed by Statistical product and service solutions (SPSS) 23.0 statistical analysis for unpaired t test,analysis of variance and Spearman's correlations analysis.Results ① New-onset RA patients with less than 12 weeks disease duration and never accepted any drugs had a significantly lower frequency of peripheral blood memory B cells,including non-switched memory B cells [(8 ±4)％ vs (13 ±4)％,P＜0.05,t =3.3)] and switched memory B cells [(18±10)％ vs (23±7)％,P＜0.05,t=2.2)],than healthy individuals.② There was a negative association between non-switched memory B cells and disease activity score in 28 joints (r=-0.23,P＜0.05).③ Negative association between non-switched memory B cells and erythrocyte sedimentation rate (ESR),lgG was found,while therewas no association between pre-switched B cells and other laboratory test results.④ Non-switched memory B cells and switched memory B cells increased after TNF-α arntagonist or DMARDs therapy.Conclusion The results of this study suggest that B cell abnormalities in new-onset RA patients with short disease duration are reduced non-switched memory B cells and switched memory B cells.A negative correlation has been found between non-switched memory B cells and ESR and lgG.B cells subsets frequency are changed by TNF-α antagonist and DMARDs,which suggests that changes of B cell subsets may contribute to the occurrence and development of RA.

Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis

Etanercept Attenuates Collagen-Induced Arthritis by Modulating the Association Between BAFFR Expression and the Production of Splenic Memory B Cells.

BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-κB Pathway and the Effects of CP-25.

Over-expression of PTEN Attenuates the Inflammation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis

[Functional Status of T Helper Cells in Rheumatoid Arthritis and Effect of Etanercept].

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Etanercept Inhibits Synovial Inflammation and Reduces the Expression of Adhesion Related Molecules in Synovial Tissues of Patients with Rheumatoid Arthritis

Efficiency and Safety of Etanercept in Patients with Rheumatoid Arthritis: an Open-Label Controlled Trial

BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis

Clinical study on etanercept combined with methotrexate for treatment of early rheumatoid arthritis

Abberant CD200/CD200R1 Pathway Contribute to the Immunopathogenesis of Rheumatoid Arthritis

Therapeutic Use of Etanercept in Rheumatoid Arthritis

Disturbance of peripheral blood B cells homeostasis in rheumatoid arthritis and the influence of therapy on B cells homeostasis

An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis

High Frequencies of Activated B Cells and T Follicular Helper Cells Are Correlated with Disease Activity in Patients with New-Onset Rheumatoid Arthritis.

The impact of anti-TNF rcMAb to Th cell subsets of rheumatoid arthritis

Increased Serum Levels of Brain-Derived Neurotrophic Factor Contribute to Inflammatory Responses in Patients with Rheumatoid Arthritis

Aberrant CD200/CD200R1 Expression and Its Potential Role in Th17 Cell Differentiation, Chemotaxis and Osteoclastogenesis in Rheumatoid Arthritis

The Expression and Significance of Costimulatory Molecule in Peripheral Blood B Lymphocytes in Rheumatoid Arthritis

Therapeutic Effects of a Novel BAFF Blocker on Arthritis

Effect of a Recombinant Human Tumor Necrosis Factor Receptor-Fc Fusion Protein on Pro-and Anti-Inflammatory Cytokines in Rheumatoid Arthritis